|
Rimawi, Mothaffar F; De Angelis, Carmine; Contreras, Alejandro et al. (2018) Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer. Breast Cancer Res Treat 167:731-740
|
|
Gates, Leah A; Gu, Guowei; Chen, Yue et al. (2018) Proteomic profiling identifies key coactivators utilized by mutant ER? proteins as potential new therapeutic targets. Oncogene 37:4581-4598
|
|
Carron, Emily C; Homra, Samuel; Rosenberg, Jillian et al. (2017) Macrophages promote the progression of premalignant mammary lesions to invasive cancer. Oncotarget 8:50731-50746
|
|
Gelsomino, Luca; Gu, Guowei; Rechoum, Yassine et al. (2016) ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling. Breast Cancer Res Treat 157:253-265
|
|
Gu, Guowei; Fuqua, Suzanne A W (2016) ESR1 Mutations in Breast Cancer: Proof-of-Concept Challenges Clinical Action. Clin Cancer Res 22:1034-6
|
|
Fuqua, Suzanne A W; Rechoum, Yassine; Gu, Guowei (2016) ESR1 Mutations in Cell-Free DNA of Breast Cancer: Predictive ""Tip of the Iceberg"". JAMA Oncol 2:1315-1316
|
|
Ciupek, Andrew; Rechoum, Yassine; Gu, Guowei et al. (2015) Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ER?-positive breast cancer. Breast Cancer Res Treat 154:225-37
|
|
Gu, Guowei; Gelsomino, Luca; Covington, Kyle R et al. (2015) Targeting thyroid hormone receptor beta in triple-negative breast cancer. Breast Cancer Res Treat 150:535-45
|
|
Rechoum, Yassine; Rovito, Daniela; Iacopetta, Domenico et al. (2014) AR collaborates with ER? in aromatase inhibitor-resistant breast cancer. Breast Cancer Res Treat 147:473-85
|
|
Fuqua, Suzanne A W; Gu, Guowei; Rechoum, Yassine (2014) Estrogen receptor (ER) ? mutations in breast cancer: hidden in plain sight. Breast Cancer Res Treat 144:11-9
|
Showing the most recent 10 out of 51 publications
